Stock Ratings / Health Care / KNSA / forecast

LLY (72) JNJ (66) ABBV (71) UNH (70) ⌘ Pro Terminal →

Kiniksa Pharmaceuticals International plc Class A (KNSA) 12-Month Stock Forecast & Price Target Cone

$97.56 +2.50% NASDAQ • Public Delayed / 60s Snapshot

Kiniksa Pharmaceuticals International plc Class A (KNSA) receives a Roarable Rating of D+ (Sell) and flashes a Red SELL / AVOID warning (64/100 RQD Confidence). Our SEC filing scanner spotted paper earnings outpacing real operating cash flow (+0.0% (NI vs OCF)) while unpaid customer invoices grew—a classic sign to step aside until cash flow catches up.

ROARABLE D+ • SELL / AVOID Cap $7.67B

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERSELL / AVOID • D+

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

5-PILLAR SNOWFLAKE RADARRw C · Rk D

Each axis scored 0–20

12M PRICE TARGET CONE+2.7% Base Target

WHALE OPTIONS TUG-OF-WAR:58% Call Buyers ($2.6M)

42% PutsMax Pain: $96.00

INTERACTIVE 12-MONTH POSITION SIMULATOR

Drag to Test Your KNSA Position Size: $10,000

Shares at $97.56: 102.5 sh

$1,000$10,000$25,000$50,000$100,000

12M Bear Case FloorTarget $78.15

$8,010

$-1,990 (-19.9%)

12M Consensus BaseTarget $100.19

$10,270

+$270 (+2.7%)

12M Bull Case BreakoutTarget $118.22

$12,118

+$2,118 (+21.2%)

Wall Street Analyst Breakdown & Historical Accuracy Audit (28 Desks)

Street Historical Accuracy: 64/100

● Strong Buy / Buy: 17● Hold: 9● Sell: 2

Wall Street Firm	Stance	12M Target	1Y Accuracy	Track Grade
Morgan StanleyInstitutional Equity Desk	HOLD	$104	74%	A
Goldman SachsSector Coverage Lead	BUY	$111	69%	B
JP MorganUS Large-Cap Research	HOLD	$89	58%	C

🔴 SUNDAY NIGHT PREP • 7:00 PM ETHosted Live by Perry Belcher & Guest Forensic Quant Desk

Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring KNSA)

✓Live walkthrough of KNSA's RQD Radar, SEC cash-conversion gap & downside levels
✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
✓Includes instant 24/7 email alert whenever any of your stocks flip to Red

RQD INSIDER CLUB UPGRADE$49/YEAR

Want Plain-English AI Custom Indicators, Daily Pro Trader Video Clips & SMS Crash Alerts?

🤖 Try AI Indicator Builder ($49/yr VIP) →$100K Arena

KNSA // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +71.51%▲ ASCENDING CHANNEL

2026-10-30O $97.40H $98.48L $91.25C $92.24VOL 1.32M

RES: $111.7SUP: $71.28SMA50: $79.16SMA200: $60.21

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

KNSA Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 KNSA Butterfly Map → + Track KNSA →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

48.0%/yr Implied 5Y Growth

vs. +60.1% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on KNSA today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for KNSA. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for KNSA today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

KNSA Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is KNSA's 12-month stock price target?

Kiniksa Pharmaceuticals International plc Class A (KNSA) carries a 12-month consensus base price target of $100.19 (+2.7% from $97.56), with a bull-case target of $118.22 and a bear-case floor of $78.15.

Is KNSA stock a Buy, Hold, or Sell right now?

Roarable's 5-Pillar RQD Quant Engine rates KNSA D+ (Sell — SELL) with an RQD Confidence score of 64/100.

Direct Sub-Reports: KNSA RQD Cockpit KNSA 12M Forecast KNSA Earnings & Move KNSA Dividends & DRIP KNSA Insiders & 13F KNSA Whale Options KNSA Profit Sankey KNSA News & Why